908 Devices Inc. (MASS)
Company Description
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets.
The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis.
It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.

Country | United States |
IPO Date | Dec 18, 2020 |
Industry | Medical - Devices |
Sector | Healthcare |
Employees | 246 |
CEO | Joseph H. Griffith IV |
Contact Details
Address: 645 Summer Street Boston, Massachusetts United States | |
Website | https://www.908devices.com |
Stock Details
Ticker Symbol | MASS |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001555279 |
CUSIP Number | 65443P102 |
ISIN Number | US65443P1021 |
Employer ID | 45-4524096 |
SIC Code | 3829 |
Key Executives
Name | Position |
---|---|
Joseph H. Griffith IV | Chief Financial Officer & Treasurer |
Dr. Christopher David Brown Ph.D. | Co-Founder & Board Advisor |
Michael S. Turner Esq., J.D. | Chief Legal & Administrative Officer and Secretary |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Apr 28, 2025 | ARS | Filing |
Apr 28, 2025 | DEFA14A | Filing |
Apr 28, 2025 | DEF 14A | Filing |
Apr 25, 2025 | SCHEDULE 13G/A | [Amend] Filing |
Apr 07, 2025 | SCHEDULE 13G | Filing |
Mar 14, 2025 | 3 | Filing |
Mar 07, 2025 | 8-K/A | [Amend] Current Report |
Mar 07, 2025 | S-8 | Filing |
Mar 07, 2025 | 10-K | Annual Report |
Mar 05, 2025 | 4 | Filing |